VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PANDEMIC POTENTIAL

DEFINITIVE CONTRACT won by VIR BIOTECHNOLOGY, INC. · work in SAN FRANCISCO, CA
$65,867,804
RecipientVIR BIOTECHNOLOGY, INC. UEI VAGNEFK9N5X7
Award ID75A50122C00081
Award amount$65,867,804
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN11
Start dateSep 30, 2022
End dateJan 31, 2026
Place of performanceSAN FRANCISCO, CA
Record updatedAug 5, 2025

View the official award record

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids